Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation
Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R.
Transplantation Proceedings 21(1 Part 2): 2258-2259
1989
ISSN/ISBN: 0041-1345 PMID: 2652734 Document Number: 328454
Document emailed within 1 workday
Related Documents
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639Hiesse, C.; Lantz, O.; Kriaa, F.; Noury, J.; Fries, D.; Charpentier, B.; Bazin, H. 1991: Treatment with Lo-Tact-1, a monoclonal antibody to the interleukin-2 receptor, in kidney transplantation Presse Medicale 20(40): 2036-2038
Frenken, L.A.; Hoitsma, A.J.; Tax, W.J.; Koene, R.A. 1991: Prophylactic use of anti-CD3 monoclonal antibody WT32 in kidney transplantation Transplantation Proceedings 23(1 Part 2): 1072-1073
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Kovarik, J.M.; Rawlings, E.; Sweny, P.; Fernando, O.; Moore, R.; Griffin, P.J.; Fauchald, P.; Albrechtsen, D.; Sodal, G.; Nordal, K.; Amlot, P.L. 1996: Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHi 621 in renal transplantation Transplantation Proceedings 28(2): 913-914
Sugawara, I.; Ikeuchi, T.; Fukuchi, K.; Yoshikai, Y.; Sugiyama, H.; Kodo, H.; Mori, S. 1990: Establishment and characterization of a non-T, non-B cell lymphoma cell line with T cell receptor beta- and gamma-chain gene rearrangement and possessing MRK 20 monoclonal antibody-defined 85KD protein Human Cell 3(1): 57-64
Yoshimura, N.; Lee, C.J.; Shiho, O.; Kita, M.; Imanishi, J.; Oka, T. 1995: Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells Transplantation Proceedings 27(1): 390-391
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Schwinzer, R.; Schlitt, H.J.; Wonigeit, K. 1991: Preferential activation of CD45RA+ cells by a monoclonal antibody to the alpha/beta T-cell receptor Transplantation Proceedings 23(1 Part 1): 277-278
Otto, G.; Hofmann, W.J.; Gaweco, A.S.; Seelos, R.; Herfarth, C.; Meuer, S. 1996: Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation Transplantation Proceedings 28(6): 3210-3211
Wang, Z-hui.; Liao, Y-hua.; Yuan, J.; Zhang, L.; Wang, M.; Zhang, J-hui.; Liu, Z-ping.; Dong, J-hua. 2007: A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy Chinese Medical Journal 120(15): 1319-1325
Koyama, I.; Amemiya, H.; Taguchi, Y.; Watanabe, T.; Nagashima, N.; Suzuki, S.; Omoto, R. 1991: Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation Transplantation Proceedings 23(1 Part 2): 1096-1098
Haga, M.; Tsuchida, M.; Hirahara, H.; Watanabe, T.; Hayashi, J.I.; Watanabe, H.; Matsumoto, Y.; Abo, T.; Eguchi, S. 2000: Synergistic effect of anti-T cell receptor monoclonal antibody and 15-deoxyspergualin on cardiac xenograft survival in a mouse-to-rat model Transplantation 69(12): 2613-2621
Knight, R.J.; Kurrle, R.; McClain, J.; Racenberg, J.; Baghdahsarian, V.; Kerman, R.; Lewis, R.; van Buren, C.T.; Kahan, B.D. 1994: Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor Transplantation 57(11): 1581-1588
Lemmens, H.P.; Langrehr, J.M.; Bechstein, W.O.; Blumhardt, G.; Keck, H.; Lüsebrink, R.; Knoop, M.; Lohmann, R.; Tullius, S.; Lobeck, H. 1995: Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial Transplantation Proceedings 27(1): 1140-1141
Bechstein, W.O.; Neuhaus, P.; McMaster, P.; Calne, R.; Pichlmayr, R.; Otto, G.; Williams, R.; Ericzon, B.G.; Bismuth, H. 1996: Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation Transplantation Proceedings 28(2): 1008-1010
Chen, B.; Cai, X.J.; Zhou, S.J. 1994: Antitumor activity of monoclonal antibody MI2 against immunosuppressive acidic protein in vitro Zhonghua Nei Ke Za Zhi 33(8): 531-533
Shaffer, D.; Simpson, M.A.; Milford, E.L.; Gottschalk, R.; Kut, J.P.; Maki, T.; Monaco, A.P. 1991: Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets Transplantation Proceedings 23(1 Pt 1): 679-681
Takamori, M.; Okumura, S.; Yasuda, A. 1986: Presynaptic modification of neuromuscular transmission by antiacetylcholine receptor antibody: myasthenic serum and monoclonal antibody produced by transformed lymphocytes Neurology 36(7): 942-947
Lord, R.H.; Hancock, W.W.; Colby, A.J.; Padberg, W.; Diamantstein, T.; Kupiec-Weglinski, J.W.; Tilney, N.L. 1987: Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat Transplantation Proceedings 19(1 Part 1): 354-355